All in Bio
2 known investors
Find your way into All in Bio
Sign up to see every warm intro you have to All in Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the All in Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.
Investors · 2
Frequently asked questions
- What does All in Bio do?
- ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.
- Who are All in Bio's investors?
- All in Bio's investors include +ND Capital, Artis Ventures.

